MX2013014937A - Cultivo de celulas de mamifero. - Google Patents
Cultivo de celulas de mamifero.Info
- Publication number
- MX2013014937A MX2013014937A MX2013014937A MX2013014937A MX2013014937A MX 2013014937 A MX2013014937 A MX 2013014937A MX 2013014937 A MX2013014937 A MX 2013014937A MX 2013014937 A MX2013014937 A MX 2013014937A MX 2013014937 A MX2013014937 A MX 2013014937A
- Authority
- MX
- Mexico
- Prior art keywords
- cell culture
- mammalian cell
- cells
- provides
- cell
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title abstract 3
- 210000004962 mammalian cell Anatomy 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 abstract 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
- 229960001230 asparagine Drugs 0.000 abstract 1
- 235000009582 asparagine Nutrition 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 235000003642 hunger Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/99—Serum-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
Abstract
La invención proporciona un método para el cultivo de células de mamífero. El método proporciona un mayor control en el crecimiento celular para obtener cultivos celulares con títulos elevados de productos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161503737P | 2011-07-01 | 2011-07-01 | |
PCT/US2012/045070 WO2013006479A2 (en) | 2011-07-01 | 2012-06-29 | Mammalian cell culture |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013014937A true MX2013014937A (es) | 2014-04-16 |
MX351974B MX351974B (es) | 2017-11-06 |
Family
ID=46579326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013014937A MX351974B (es) | 2011-07-01 | 2012-06-29 | Cultivo de celulas de mamifero. |
Country Status (24)
Country | Link |
---|---|
US (7) | US11292829B2 (es) |
EP (2) | EP2837680B1 (es) |
JP (1) | JP5897708B2 (es) |
KR (7) | KR101662412B1 (es) |
CN (2) | CN107988166B (es) |
AU (5) | AU2012279230B2 (es) |
BR (2) | BR122021007265B1 (es) |
CA (2) | CA2838695C (es) |
CL (2) | CL2013003792A1 (es) |
CY (2) | CY1118863T1 (es) |
DK (2) | DK2726600T3 (es) |
EA (1) | EA039023B1 (es) |
ES (2) | ES2788132T3 (es) |
HK (2) | HK1197081A1 (es) |
HU (2) | HUE049119T2 (es) |
IL (5) | IL297998B1 (es) |
LT (2) | LT2726600T (es) |
MX (1) | MX351974B (es) |
PL (2) | PL2837680T3 (es) |
PT (2) | PT2726600T (es) |
SG (1) | SG10201702537RA (es) |
SI (2) | SI2837680T1 (es) |
WO (1) | WO2013006479A2 (es) |
ZA (1) | ZA201309372B (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201708537A (zh) | 2006-09-13 | 2017-03-01 | 艾伯維有限公司 | 細胞培養改良 |
US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
CN104974251A (zh) | 2008-10-20 | 2015-10-14 | Abbvie公司 | 在抗体纯化过程中的病毒灭活 |
AU2009347206C1 (en) | 2008-10-20 | 2016-12-08 | Abbvie Inc. | Isolation and purification of antibodies using Protein A affinity chromatography |
WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
CN107988166B (zh) * | 2011-07-01 | 2022-03-15 | 美国安进公司 | 哺乳动物细胞培养 |
US10485869B2 (en) | 2011-10-18 | 2019-11-26 | Coherus Biosciences, Inc. | Etanercept formulations stabilized with meglumine |
WO2013059407A1 (en) | 2011-10-18 | 2013-04-25 | Coherus Biosciences, Inc. | Etanercept formulations stabilized with sodium chloride |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
WO2013158279A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
WO2013176754A1 (en) | 2012-05-24 | 2013-11-28 | Abbvie Inc. | Novel purification of antibodies using hydrophobic interaction chromatography |
EP2869816A4 (en) | 2012-07-09 | 2016-04-20 | Coherus Biosciences Inc | FORMANTS OF ETANERCEPT HAVING A REDUCTION MARKED IN INVISIBLE PARTICLES IN THE NU |
SG11201504249XA (en) | 2012-09-02 | 2015-07-30 | Abbvie Inc | Methods to control protein heterogeneity |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
CN110051823A (zh) | 2012-09-11 | 2019-07-26 | 科荣生生物科学公司 | 高纯度和优异产量的正确折叠的依那西普 |
US20150353542A1 (en) * | 2013-01-14 | 2015-12-10 | Amgen Inc. | Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture |
EP2830651A4 (en) | 2013-03-12 | 2015-09-02 | Abbvie Inc | HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
TWI720289B (zh) | 2013-03-14 | 2021-03-01 | 美商安美基公司 | 用於增加重組蛋白質之甘露糖含量之方法 |
US8921526B2 (en) | 2013-03-14 | 2014-12-30 | Abbvie, Inc. | Mutated anti-TNFα antibodies and methods of their use |
WO2014160790A1 (en) | 2013-03-26 | 2014-10-02 | Coherus Biosciences, Inc. | Protein production method |
US9481901B2 (en) | 2013-05-30 | 2016-11-01 | Amgen Inc. | Methods for increasing mannose content of recombinant proteins |
WO2015051293A2 (en) | 2013-10-04 | 2015-04-09 | Abbvie, Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
US11390663B2 (en) | 2013-10-11 | 2022-07-19 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
CA2929077A1 (en) * | 2013-10-31 | 2015-05-07 | Amgen Inc. | Use of monensin to regulate glycosylation of recombinant proteins |
US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
WO2015095809A1 (en) | 2013-12-20 | 2015-06-25 | Biogen Idec Ma Inc. | Use of perfusion seed cultures to improve biopharmaceutical fed-batch production capacity and product quality |
SG11201605640UA (en) | 2014-01-13 | 2016-08-30 | Amgen Inc | Regulating ornithine metabolism to manipulate the high mannose glycoform content of recombinant proteins |
MX362923B (es) | 2014-01-30 | 2019-02-25 | Coherus Biosciences Inc | Medios de perfusión. |
IL249150B (en) | 2014-06-04 | 2022-09-01 | Amgen Inc | Methods for collecting mammalian cell cultures |
TW202204596A (zh) | 2014-06-06 | 2022-02-01 | 美商健臻公司 | 灌注培養方法及其用途 |
TWI707949B (zh) * | 2014-06-09 | 2020-10-21 | 美商健臻公司 | 種子罐培養法(seed train processes)及其用途 |
JP6530171B2 (ja) * | 2014-09-09 | 2019-06-12 | 旭化成メディカル株式会社 | 培養産生物の回収方法 |
SG10202002458PA (en) * | 2014-12-01 | 2020-04-29 | Amgen Inc | Process for manipulating the level of glycan content of a glycoprotein |
KR102007930B1 (ko) | 2014-12-31 | 2019-08-06 | 주식회사 엘지화학 | 재조합 당단백질의 글리코실화 조절 방법 |
CN105385731B (zh) * | 2015-12-25 | 2018-10-30 | 上海莱士血液制品股份有限公司 | 一种表达重组八因子的灌注培养方法 |
CN109153717A (zh) * | 2016-01-06 | 2019-01-04 | 安口生物公司 | 减少单克隆抗体组合物中的高分子量物类、酸性电荷物类和片段 |
AU2017213775A1 (en) | 2016-02-03 | 2018-08-16 | Outlook Therapeutics, Inc. | Buffer formulations for enhanced antibody stability |
US11377677B2 (en) | 2016-03-02 | 2022-07-05 | Lonza Ltd | Fermentation process |
CA3054593A1 (en) * | 2017-03-31 | 2018-10-04 | Boehringer Ingelheim International Gmbh | Perfusion medium |
KR102604992B1 (ko) * | 2017-03-31 | 2023-11-24 | 베링거 인겔하임 인터내셔날 게엠베하 | 관류 배지 |
US11851678B2 (en) | 2017-08-09 | 2023-12-26 | Juno Therapeutics, Inc. | Methods for producing genetically engineered cell compositions and related compositions |
CN111344558A (zh) | 2017-10-06 | 2020-06-26 | 龙沙有限公司 | 使用拉曼光谱法自动控制细胞培养 |
EP4039786A1 (en) | 2017-10-16 | 2022-08-10 | Regeneron Pharmaceuticals, Inc. | Perfusion bioreactor and related methods of use |
CA3084445A1 (en) * | 2017-12-08 | 2019-06-13 | Juno Therapeutics, Inc. | Process for producing a composition of engineered t cells |
AU2019419406B2 (en) * | 2018-12-31 | 2023-05-18 | Repligen Corporation | Filter for mammalian cell culture perfusion and clarification with hydrophobic hollow fiber |
US20230313259A1 (en) * | 2020-08-14 | 2023-10-05 | Bristol-Myers Squibb Company | Manufacturing process for protein |
KR20230058094A (ko) * | 2020-08-31 | 2023-05-02 | 리제너론 파아마슈티컬스, 인크. | 세포 배양 성능을 개선하고 아스파라긴 서열 변이체를 완화하기 위한 아스파라긴 공급 전략 |
CN114574430A (zh) * | 2022-03-22 | 2022-06-03 | 成都博宠生物科技有限公司 | 一种Expi293F细胞培养方法 |
CN115287251A (zh) * | 2022-08-25 | 2022-11-04 | 无锡药明生物技术股份有限公司 | 间歇性灌流联合分批流加培养 |
WO2024054414A1 (en) | 2022-09-06 | 2024-03-14 | Amgen Inc. | Lean perfusion cell culture methods |
WO2024059235A2 (en) | 2022-09-16 | 2024-03-21 | Amgen Inc. | A method for harvesting products from perfusion cultures |
CN116790483B (zh) * | 2023-08-22 | 2023-10-20 | 苏州依科赛生物科技股份有限公司 | 一种cho细胞无血清培养基及其应用 |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936694B1 (en) | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
US4499064A (en) | 1982-06-03 | 1985-02-12 | Clayton Foundation For Research | Assessment of nutritional status of individuals |
AU588819B2 (en) | 1984-10-29 | 1989-09-28 | Immunex Corporation | Cloning of human granulocyte-macrophage colony stimulating factor gene |
US5672502A (en) | 1985-06-28 | 1997-09-30 | Celltech Therapeutics Limited | Animal cell culture |
US4816401A (en) * | 1985-09-09 | 1989-03-28 | University Of Rochester | Serum free cell culture medium |
US5045468A (en) * | 1986-12-12 | 1991-09-03 | Cell Enterprises, Inc. | Protein-free culture medium which promotes hybridoma growth |
US4968607A (en) | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
AU643427B2 (en) | 1988-10-31 | 1993-11-18 | Immunex Corporation | Interleukin-4 receptors |
US5143842A (en) * | 1988-11-01 | 1992-09-01 | The University Of Colorado Foundation, Inc. | Media for normal human muscle satellite cells |
US5395760A (en) | 1989-09-05 | 1995-03-07 | Immunex Corporation | DNA encoding tumor necrosis factor-α and -β receptors |
DE10399023I2 (de) | 1989-09-12 | 2006-11-23 | Ahp Mfg B V | TFN-bindende Proteine |
US6204363B1 (en) | 1989-10-16 | 2001-03-20 | Amgen Inc. | Stem cell factor |
US5149792A (en) | 1989-12-19 | 1992-09-22 | Amgen Inc. | Platelet-derived growth factor B chain analogs |
US5272064A (en) | 1989-12-19 | 1993-12-21 | Amgen Inc. | DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof |
US7037721B1 (en) * | 1990-01-29 | 2006-05-02 | Hy-Gene Biomedical, Inc. | Protein-free defined media for the growth of normal human keratinocytes |
US5292655A (en) * | 1990-01-29 | 1994-03-08 | Wille Jr John J | Method for the formation of a histologically-complete skin substitute |
WO1991018982A1 (en) | 1990-06-05 | 1991-12-12 | Immunex Corporation | Type ii interleukin-1 receptors |
US5350683A (en) | 1990-06-05 | 1994-09-27 | Immunex Corporation | DNA encoding type II interleukin-1 receptors |
GB9118664D0 (en) | 1991-08-30 | 1991-10-16 | Celltech Ltd | Cell culture |
WO1994010308A1 (en) | 1992-10-23 | 1994-05-11 | Immunex Corporation | Methods of preparing soluble, oligomeric proteins |
US5554512A (en) | 1993-05-24 | 1996-09-10 | Immunex Corporation | Ligands for flt3 receptors |
US6310185B1 (en) | 1994-03-08 | 2001-10-30 | Memorial Sloan Kettering Cancer Center | Recombinant human anti-Lewis Y antibodies |
US5856179A (en) | 1994-03-10 | 1999-01-05 | Genentech, Inc. | Polypeptide production in animal cell culture |
US5981713A (en) | 1994-10-13 | 1999-11-09 | Applied Research Systems Ars Holding N.V. | Antibodies to intereleukin-1 antagonists |
DK1666591T3 (da) | 1995-06-29 | 2011-05-23 | Immunex Corp | Cytokin der inducerer apoptose |
US6613544B1 (en) | 1995-12-22 | 2003-09-02 | Amgen Inc. | Osteoprotegerin |
US6096728A (en) | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
WO1998008934A1 (en) | 1996-08-30 | 1998-03-05 | Life Technologies, Inc. | Serum-free mammalian cell culture medium, and uses thereof |
US6271349B1 (en) | 1996-12-23 | 2001-08-07 | Immunex Corporation | Receptor activator of NF-κB |
US20020012991A1 (en) | 1997-04-07 | 2002-01-31 | Florence Chua Nee Ho Kit Fong | Cell culture media for enhanced protein production |
US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
US6337072B1 (en) | 1998-04-03 | 2002-01-08 | Hyseq, Inc. | Interleukin-1 receptor antagonist and recombinant production thereof |
AU1920301A (en) | 1999-11-17 | 2001-05-30 | Immunex Corporation | Receptor activator of nf-kappa b |
US6544424B1 (en) | 1999-12-03 | 2003-04-08 | Refined Technology Company | Fluid filtration system |
US20030036505A1 (en) | 2000-09-25 | 2003-02-20 | Human Genome Sciences, Inc. | Signal transduction pathway component polynucleotides, polypeptides, antibodies and methods based thereon |
WO2002101019A2 (en) | 2001-06-13 | 2002-12-19 | Genentech, Inc. | Methods of culturing animal cells and polypeptide production in animal cells |
US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
AU2003220529B2 (en) | 2002-03-27 | 2006-09-07 | Immunex Corporation | Methods for increasing polypeptide production |
PT1720972E (pt) * | 2004-03-05 | 2014-04-07 | Dsm Ip Assets Bv | Processo para cultura de células por perfusão contínua e fluxo alternativo tangencial |
CN1332024C (zh) * | 2004-06-09 | 2007-08-15 | 中国科学院大连化学物理研究所 | 一种海绵细胞的微载体三维培养方法 |
ATE505219T1 (de) | 2004-07-07 | 2011-04-15 | Coloplast As | Katheter enthaltend estane 58212 |
TWI374935B (en) * | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
US7294484B2 (en) * | 2004-08-27 | 2007-11-13 | Wyeth Research Ireland Limited | Production of polypeptides |
US7598083B2 (en) * | 2004-10-29 | 2009-10-06 | Centocor, Inc. | Chemically defined media compositions |
JP5199073B2 (ja) | 2005-06-03 | 2013-05-15 | アレス トレーディング ソシエテ アノニム | 組換えil−18結合タンパク質の生産 |
CN104263700A (zh) | 2006-07-14 | 2015-01-07 | 帝斯曼知识产权资产管理有限公司 | 改进的细胞培养方法 |
WO2008024769A2 (en) * | 2006-08-21 | 2008-02-28 | Raven Biotechnologies, Inc. | Intensified perfusion production method |
CN101535469A (zh) | 2006-11-08 | 2009-09-16 | 惠氏公司 | 合理设计的细胞培养基 |
WO2008154014A2 (en) | 2007-06-11 | 2008-12-18 | Amgen Inc. | A method for culturing mammalian cells to improve recombinant protein production |
US20090042253A1 (en) | 2007-08-09 | 2009-02-12 | Wyeth | Use of perfusion to enhance production of fed-batch cell culture in bioreactors |
MX347112B (es) | 2008-09-15 | 2017-04-12 | Genentech Inc | Composiciones y metodos para regular osmolaridad celular. |
CN101603026B (zh) * | 2009-06-19 | 2011-01-19 | 华东理工大学 | 适于动物细胞产品生产的无动物来源低蛋白培养基 |
CN102549145B (zh) | 2009-07-31 | 2015-05-20 | 巴克斯特国际公司 | 用于adamts蛋白表达的细胞培养基 |
US8580554B2 (en) | 2009-07-31 | 2013-11-12 | Baxter International Inc. | Method of producing a polypeptide or virus of interest in a continuous cell culture |
RU2639288C2 (ru) | 2009-08-11 | 2017-12-20 | Дженентек, Инк. | Получение белков в культуральных средах без глутамина |
RS56484B1 (sr) | 2009-11-17 | 2018-01-31 | Squibb & Sons Llc | Metode za poboljšanu proizvodnju proteina |
WO2011065940A1 (en) | 2009-11-24 | 2011-06-03 | Biogen Idec Ma Inc. | Method of supplementing culture media to prevent undesirable amino acid substitutions |
AU2011324870B2 (en) * | 2010-11-01 | 2015-01-29 | Symphogen A/S | pan-HER antibody composition |
US9133493B2 (en) * | 2011-04-21 | 2015-09-15 | Amgen Inc. | Method for culturing mammalian cells to improve recombinant protein production |
CN107988166B (zh) * | 2011-07-01 | 2022-03-15 | 美国安进公司 | 哺乳动物细胞培养 |
TWI720289B (zh) | 2013-03-14 | 2021-03-01 | 美商安美基公司 | 用於增加重組蛋白質之甘露糖含量之方法 |
CA2929077A1 (en) | 2013-10-31 | 2015-05-07 | Amgen Inc. | Use of monensin to regulate glycosylation of recombinant proteins |
AU2016357567B2 (en) * | 2015-11-17 | 2020-05-07 | Pfizer Inc. | Media and fermentation methods for producing polysaccharides in bacterial cell culture |
-
2012
- 2012-06-29 CN CN201711406697.2A patent/CN107988166B/zh active Active
- 2012-06-29 DK DK12738674.6T patent/DK2726600T3/en active
- 2012-06-29 PT PT127386746T patent/PT2726600T/pt unknown
- 2012-06-29 CN CN201280032874.4A patent/CN103827292B/zh active Active
- 2012-06-29 SG SG10201702537RA patent/SG10201702537RA/en unknown
- 2012-06-29 CA CA2838695A patent/CA2838695C/en not_active Expired - Fee Related
- 2012-06-29 ES ES14187232T patent/ES2788132T3/es active Active
- 2012-06-29 HU HUE14187232A patent/HUE049119T2/hu unknown
- 2012-06-29 SI SI201231761T patent/SI2837680T1/sl unknown
- 2012-06-29 JP JP2014519184A patent/JP5897708B2/ja active Active
- 2012-06-29 KR KR1020147001985A patent/KR101662412B1/ko active IP Right Grant
- 2012-06-29 IL IL297998A patent/IL297998B1/en unknown
- 2012-06-29 IL IL288509A patent/IL288509B2/en unknown
- 2012-06-29 KR KR1020237024499A patent/KR20230114317A/ko active IP Right Grant
- 2012-06-29 KR KR1020227003428A patent/KR102558247B1/ko active IP Right Grant
- 2012-06-29 LT LTEP12738674.6T patent/LT2726600T/lt unknown
- 2012-06-29 ES ES12738674.6T patent/ES2625045T3/es active Active
- 2012-06-29 HU HUE12738674A patent/HUE033279T2/en unknown
- 2012-06-29 BR BR122021007265-5A patent/BR122021007265B1/pt active IP Right Grant
- 2012-06-29 US US14/127,050 patent/US11292829B2/en active Active
- 2012-06-29 EP EP14187232.5A patent/EP2837680B1/en active Active
- 2012-06-29 AU AU2012279230A patent/AU2012279230B2/en active Active
- 2012-06-29 WO PCT/US2012/045070 patent/WO2013006479A2/en active Application Filing
- 2012-06-29 KR KR1020187012639A patent/KR102108663B1/ko active IP Right Grant
- 2012-06-29 LT LTEP14187232.5T patent/LT2837680T/lt unknown
- 2012-06-29 KR KR1020237043604A patent/KR20240005106A/ko not_active Application Discontinuation
- 2012-06-29 MX MX2013014937A patent/MX351974B/es active IP Right Grant
- 2012-06-29 KR KR1020167015700A patent/KR101857380B1/ko active IP Right Grant
- 2012-06-29 PL PL14187232T patent/PL2837680T3/pl unknown
- 2012-06-29 EA EA201391826A patent/EA039023B1/ru unknown
- 2012-06-29 PL PL12738674T patent/PL2726600T3/pl unknown
- 2012-06-29 IL IL310968A patent/IL310968A/en unknown
- 2012-06-29 KR KR1020207012533A patent/KR102358951B1/ko active IP Right Grant
- 2012-06-29 EP EP12738674.6A patent/EP2726600B1/en not_active Revoked
- 2012-06-29 CA CA2952347A patent/CA2952347A1/en not_active Abandoned
- 2012-06-29 PT PT141872325T patent/PT2837680T/pt unknown
- 2012-06-29 BR BR112013033730-3A patent/BR112013033730B1/pt active IP Right Grant
- 2012-06-29 DK DK14187232.5T patent/DK2837680T3/da active
- 2012-06-29 SI SI201230945A patent/SI2726600T1/sl unknown
-
2013
- 2013-12-05 IL IL229803A patent/IL229803B/en active IP Right Grant
- 2013-12-10 ZA ZA2013/09372A patent/ZA201309372B/en unknown
- 2013-12-30 CL CL2013003792A patent/CL2013003792A1/es unknown
-
2014
- 2014-10-20 HK HK14110449A patent/HK1197081A1/xx unknown
- 2014-10-20 HK HK15106530.7A patent/HK1206057A1/xx unknown
-
2016
- 2016-05-18 CL CL2016001190A patent/CL2016001190A1/es unknown
- 2016-10-12 AU AU2016244255A patent/AU2016244255A1/en not_active Abandoned
-
2017
- 2017-03-22 CY CY20171100366T patent/CY1118863T1/el unknown
-
2018
- 2018-06-05 AU AU2018203972A patent/AU2018203972B2/en active Active
-
2020
- 2020-05-25 CY CY20201100473T patent/CY1123146T1/el unknown
- 2020-09-11 US US17/018,564 patent/US11673941B2/en active Active
- 2020-09-11 US US17/018,557 patent/US11634476B2/en active Active
- 2020-11-02 IL IL278430A patent/IL278430B/en unknown
- 2020-12-03 AU AU2020281075A patent/AU2020281075B2/en active Active
-
2022
- 2022-03-04 US US17/686,766 patent/US20220185869A1/en active Pending
- 2022-12-14 US US18/066,251 patent/US11685772B2/en active Active
- 2022-12-20 US US18/068,922 patent/US20230129523A1/en active Pending
-
2023
- 2023-02-24 AU AU2023201127A patent/AU2023201127A1/en active Pending
- 2023-03-08 US US18/180,828 patent/US11827692B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013014937A (es) | Cultivo de celulas de mamifero. | |
IL288185B1 (en) | New methods and mediums for growing pluripotent stem cells | |
EP4148121A3 (en) | Cell-controlled perfusion in continuous culture | |
EP2438161A4 (en) | PROCESS FOR THE PRODUCTION OF PLURIPOTENT STEM CELLS AND THEIR CULTURE PROCESS | |
SG195299A1 (en) | Expansion of stem cells in hollow fiber bioreactors | |
MY156588A (en) | Systems using cell culture for production of isoprene | |
IL212387A0 (en) | Perfusion bioreactors, cell culture systems, and methods for production of cells and cell-derived products | |
MX2012001126A (es) | Fotobiorreactores, sistemas de captacion de energia solar, y metodos de regulacion termica. | |
SG10201502242VA (en) | Culture method for causing differentiation of pluripotent mammalian cells | |
WO2011159359A3 (en) | Serum-free chemically defined cell culture medium | |
HK1191668A1 (zh) | 封閉環境中用於培養光合微生物的光生物反應器 | |
BR112015001637A2 (pt) | método usando microalgas para produção com eficiência elevada de astaxantina | |
MY186219A (en) | Production of proteins in glutamine-free cell culture media | |
ZA201206635B (en) | Cell culture medium for the growth and differentiation of cells of the hematopoietic lineage | |
SG10201810830UA (en) | Cell culture compositions and methods for polypeptide production | |
EP2532738A4 (en) | PROCESS FOR CULTURING CORNEAL ENDOTHELIAL CELLS, METHOD FOR PRODUCING CORNEAL ENDOTHELIAL CELL SHEET FOR TRANSPLANTATION, AND CULTURE KIT FOR CORNEAL ENDOTHELIAL CELLS | |
SG10201809452RA (en) | Cell culture compositions with antioxidants and methods for polypeptide production | |
IN2015DN02630A (es) | ||
WO2014074770A3 (en) | Balanced mixotrophy methods | |
GB2482612B (en) | Cell culture support for culturing mesenchymal stem cells | |
EA201490502A1 (ru) | Предварительно запрограммированное непрерывное питание культур клеток без управления по обратной связи | |
HK1221258A1 (zh) | 用於體外培養幹細胞的方法和培養基 | |
CA2865497A1 (en) | Method for guiding the derivation of endothelial cells from human pluripotent stem cells employing two-dimensional, feeder-free differentiation | |
WO2011085095A3 (en) | Enhanced protein expression | |
EP2695934A4 (en) | CULTURE KIT FOR ANIMAL CELLS, METHOD FOR LIVING ANIMAL CELLS, METHOD FOR SELECTIVATING LIVESTOCK CELLS AND CELL DIFFERENTIATION METHOD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |